OPTA (Optimal Treatment of Angina) Chronicles Launched by Abbott Healthcare Private limited: Empowering Doctors with Advanced Tools for Angina Management

Written By :  MD Brand Connect
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-07-10 06:26 GMT   |   Update On 2024-04-05 05:25 GMT

Mumbai: As one of the leading global healthcare company, Abbott is committed to connected care and shaping digital health tools to drive breakthrough in prevention, diagnosis, and treatment. It has been our constant endeavour to propagate knowledge on various diseases, disorders, therapies and to promote disease awareness, diagnosis, treatment and adherence through pioneering programs...

Login or Register to read the full article

Mumbai: As one of the leading global healthcare company, Abbott is committed to connected care and shaping digital health tools to drive breakthrough in prevention, diagnosis, and treatment. It has been our constant endeavour to propagate knowledge on various diseases, disorders, therapies and to promote disease awareness, diagnosis, treatment and adherence through pioneering programs and initiatives.

Optimal Treatment of Angina (OPTA) Chronicles is one such initiative designed to empower healthcare professionals with tools to ensure that patients with angina receive better standards of care, thus improving patient outcomes.

OPTA Chronicles aims at empowering physicians with a systematic guideline-based management of Angina. This book focuses on elements including, patient profile-based management approach for Optimal Treatment of Angina, OPTA checklist and questionnaire for physicians to screen, diagnose and risk stratify patients, the most favorable utilization of available pharmacotherapy, algorithm to manage chronic stable angina and an understanding of symptoms and classical clinical presentations. An early diagnosis and appropriate pharmacotherapy will help to ensure optimal use of resources and reduce the risk of future cardiac events.

The OPTA Chronicles is an outcome of a 6-year journey under the guidance of expert cardiologists. During these 6 years, 6 Indian consensus documents have been published that address various need-gaps in the management of Angina. Also, clinical studies have been conducted and published validating OPTA tools and understanding the applicability of these tools in real world clinical practice. OPTA has already made a significant impact, with educating over 10,000 healthcare professionals and conducting more than 2500 Continuing Medical Education (CME) programs across the country. Additionally, over 2500 expert cardiologists and senior physicians have contributed to the OPTA journey.

According to the Global Burden of Disease report, India has an age-standardized CVD mortality rate of 272 per 100,000 people, significantly higher than the global average of 2351. Indians are affected by CVDs a decade earlier than people in Western countries1. Angina, the most common manifestation of CAD, poses an undue burden on Indian healthcare system2. Early diagnosis will help in initiating interventions to reduce the risk of future cardiac events2.

Kartik Rajendran, MD & GM, Abbott’s Specialty Care Business in India said, "Abbott is committed to transforming care. Staying true to our commitment, angina diagnosis and treatment is one of our focus areas. We recognize the critical role healthcare professionals play in the accurate diagnosis and effective management of angina. With this view, the OPTA initiative is specifically designed to support HCPs in making informed decisions and helping ensure optimal treatment outcomes for patients. By empowering clinicians with practical evidence-based knowledge and resources, we aim to enable better patient care and ultimately help reduce the burden of angina in India".

Dr Ashwini Pawar, Medical Affairs Director for Abbott’s Specialty Care Business in India, further added, “This initiative will help to address the unique challenges posed by limited resources and make a positive impact in the lives of angina patients. OPTA Chronicles will play a critical role in bridging gaps in care delivery and empowering the medical professionals to better patient outcomes. Together, we can make a meaningful difference in the field of angina management and help ensure improved outcomes for those in need”

References:

1) Sreeniwas Kumar A, Sinha N. Cardiovascular disease in India: A 360 degree overview. Med J Armed Forces India. 2020;76(1):1-3. doi:10.1016/j.mjafi.2019.12.005

2) Jadhav, U., Pinto, B., Jayagopal, P. B., Nair, T., Kumar, P., Sahoo, P. K., Ganguly, A., Srivastava, S., Kapoor, S., Davidson, D., Ahuja, R. C., Dharamadhikari, A., & Singh, A. (2018). Indian Consensus on OPtimal Treatment of Angina (OPTA ). The Journal of the Association of Physicians of India, 66(12), 95–103.

This article is for the use only of registered medical practitioners or a hospital or a laboratory only. The Optimal Treatment of Angina (OPTA) initiative mentioned in the article and the OPTA book, “OPTA Chronicles” exclusively belong to Abbott Healthcare Private Limited (Abbott). The book, “OPTA Chronicles” is a compilation of content on Optimal Treatment of Angina (OPTA) which is designed by Scientimed Solutions Private Limited for Abbott. It aims to disseminate knowledge to cardiologists on OPTA. As part of a comprehensive educational program organized by Abbott on OPTA, the cardiologist Healthcare professional (HCP) experts identified in this book were engaged by Abbott Healthcare Private Limited (“Abbott”) to arrive at a consensus on the strategy to be adopted for holistic management and optimum treatment of angina. The content of the OPTA book is an outcome of the aforesaid consensus and reflects the independent views of the HCP experts in the exercise of their clinical judgment, professional autonomy and integrity. Certain parts of the article and the content in the aforesaid OPTA book is based on the cited references. It is not intended to represent Abbott’s viewpoint on the matter or to promote Abbott’s products. Nothing in this article and/or the OPTA book should be construed as Abbott giving medical advice or making a recommendation or endorsement of any kind, nor does it seek to replace medical opinion or independent professional/ clinical judgement. While every effort is made to ensure the accuracy, completeness of the content, any liability arising from the use thereof is disclaimed. © 2023 Abbott. All Rights Reserved.
#comments{display:none !important;} .shareArticle{display:none !important;}
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News